Pyrazinamide is indicated for the initial treatment of active tuberculosis in adults and children when combined with other antituberculous agents. (The current recommendation of the CDC for drug-susceptible disease is to use a six-month regimen for initial treatment of active tuberculosis, consisting of isoniazid, rifampin and pyrazinamide given for 2 months, followed by isoniazid and rifampin for 4 months.
From the U.S. FDA-approved label for Pyrazinamide. Full label: DailyMed.
Pyrazinamide is indicated for the initial treatment of active tuberculosis in adults and children when combined with other antituberculous agents. (The current recommendation of the CDC for drug-susceptible disease is to use a six-month regimen for initial treatment of active tuberculosis, consisting of isoniazid, rifampin and pyrazinamide given for 2 months, followed by isoniazid and rifampin for 4 months. *4 ) (Patients with drug-resistant disease should be treated with regimens individualized to their situation. Pyrazinamide frequently will be an important component of such therapy.) (In patients with concomitant HIV infection, the physician should be aware of current recommendations of CDC. It is possible these patients may require a longer course of treatment.) It is also indicated after treatment failure with other primary drugs in any form of active tuberculosis. Pyrazinamide should only be used in conjunction with other effective antituberculous agents.
From the U.S. FDA-approved label for Pyrazinamide. Full label: DailyMed.
Pyrazinamide should always be administered with other effective antituberculous drugs. It is administered for the initial 2 months of a 6-month or longer treatment regimen for drug-susceptible patients. Patients who are known or suspected to have drug-resistant disease should be treated with regimens individualized to their situation.
Directions from the U.S. FDA-approved label for Pyrazinamide — your doctor or pharmacist may advise differently.
Pyrazinamide is contraindicated in persons: with severe hepatic damage. who have shown hypersensitivity to it. with acute gout.
Excerpt from the U.S. FDA-approved label for Pyrazinamide. Talk to a pharmacist or doctor before use.
Patients started on pyrazinamide should have baseline serum uric acid and liver function determinations. Those patients with preexisting liver disease or those at increased risk for drug related hepatitis (e.g., alcohol abusers) should be followed closely. Pyrazinamide should be discontinued and not be resumed if signs of hepatocellular damage or hyperuricemia accompanied by an acute gouty arthritis appear.
Warnings and precautions excerpt from the U.S. FDA-approved label for Pyrazinamide — not a complete list. Talk to a pharmacist or doctor before use.
General Fever, porphyria and dysuria have rarely been reported. Gout (see PRECAUTIONS). Gastrointestinal The principal adverse effect is a hepatic reaction (see WARNINGS). Hepatotoxicity appears to be dose related, and may appear at any time during therapy. GI disturbances including nausea, vomiting and anorexia have also been reported.
Excerpt from the U.S. FDA-approved label for Pyrazinamide — not a complete list. Talk to a pharmacist or doctor about side effects.
11 brands · 5 makers in the NepalDoc catalog — see the full Pyrazinamide guide →
Store at 20° to 25°C (68° to 77°F).
Storage information from the U.S. FDA-approved label for Pyrazinamide.
What is Pyzina 1?
Pyzina 1gm Tablet is a Pyrazinamide medicine made by Lupin Ltd. It comes as 1gm Tablet.
What is Pyzina 1 used for?
According to its FDA label, Pyrazinamide is used for the initial treatment of active tuberculosis in adults and children when combined with other antituberculous agents.
What is the generic name of Pyzina 1?
The generic name of Pyzina 1 is Pyrazinamide.
Which brands of Pyrazinamide are available in Nepal?
11 brands of Pyrazinamide are listed in the NepalDoc catalog, from 5 makers — including Koxymide 750mg Tablet, Macrozide 750mg Tablet, P ZIDE 1000mg Tablet, P ZIDE 500mg Tablet, P ZIDE 750mg Tablet, Pyzina 300mg DT Tablet.
What are the side effects of Pyrazinamide?
General Fever, porphyria and dysuria have rarely been reported. Gout (see PRECAUTIONS). Gastrointestinal The principal adverse effect is a hepatic reaction (see WARNINGS). Hepatotoxicity appears to be dose related, and may appear at any time during therapy.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
Every NepalDoc section, one tap away.
Find doctors by specialty across Nepal.
